Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2025 18:46 ET | Source: Robbins LLP

Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
January 08, 2025 18:38 ET | Source: Robbins LLP

Stockholder Notice: Robbins LLP Informs Stockholders of the Regeneron Pharmaceuticals, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Regeneron Pharmaceuticals, Inc. (REGN) Misled Investors Regarding its Business Prospects
January 06, 2025 21:31 ET | Source: Robbins LLP

MGPI Stock News: Robbins LLP Urges Investors with Large Losses to Contact the Firm for Information About the MGP Ingredients, Inc. Class Action

Robbins LLP is Investigating Allegations that MGP Ingredients, Inc. (SUI) Misled Investors Regarding Demand and Inventory Levels
January 06, 2025 21:28 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Pending Class Action Against Symbotic Inc. and Urges SYM Stockholders to Seek Legal Counsel

Robbins LLP is Investigating Allegations that Symbotic Inc. (SYM) Failed to Disclose Material Weaknesses in its Internal Control Over Financial Reporting
January 06, 2025 20:38 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Pending Class Action Against Sun Communities, Inc. and Urges SUI Stockholders to Contact the Firm for Information

Robbins LLP is Investigating Allegations that Sun Communities, Inc. (SUI) Misled Investors Regarding Conflicts of Interest
January 06, 2025 20:26 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Pending Class Action Against Cassava Sciences, Inc. and Urges SAVA Stockholders to Contact the Firm for Information

Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate
January 06, 2025 20:26 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Pending Class Action Against ASP Isotopes Inc. and Urges ASPI Stockholders to Contact the Firm for Information

Robbins LLP is Investigating Allegations that ASP Isotopes Inc. (ASPI) Misled Investors Regarding its Uranium Enrichment Technology and Facility.
January 06, 2025 20:25 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Pending Class Action Against Five9, Inc. and Urges FIVN Stockholders to Contact the Firm for Information

Robbins LLP is Investigating Allegations that Five9, Inc. (FIVN) Misled Investors Regarding its Sales Execution and Efficiency Issues
January 06, 2025 19:08 ET | Source: Robbins LLP

APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.

Robbins LLP is Investigating Allegations that Applied Therapeutics, Inc. (APLT) Misled Investors Regarding its Lead Drug Candidate
January 02, 2025 16:24 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Joint Stock Company Kaspi.kz (KSPI) Class Action and Urges Investors with Large Losses to Contact the Firm

Robbins LLP is Investigating Allegations that Joint Stock Company Kaspi.kz (KSPT) Misled Investors Regarding its Dealings with Russia